Table 1.
Base-Case Clinical and Resource Use 5-Year Results
| Scenario | Diagnoses |
Screenings |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stage I or II |
Stage III |
Stage IV |
Total Lung Cancer Diagnoses | False-Positive Screens |
False-Negative Screens |
Total Screening Episodes | ||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | |||
| Low-dose CT screening scenario | 124,000 | 52.1 | 56,000 | 23.5 | 58,000 | 24.4 | 238,000 | 2,926,000 | 27.3 | 4,300 | 0.04 | 10,722,000 |
| No-screening scenario | 42,000 | 22.6 | 63,000 | 33.9 | 81,000 | 43.5 | 186,000 | 0 | 0.0 | 0 | 0.0 | 0 |
| Difference | 82,000 | 29.5 | −7,000 | −10.3 | −23,000 | −19.2% | 52,000 | 2,926,000 | 27.3 | 4,300 | 0.04 | 10,722,000 |
Abbreviation: CT, computed tomography.